Money Talks News on MSN
Testing for Alzheimer's disease could soon be a finger prick away, thanks to a revolutionary breakthrough
A new blood test could replace the brain scans and spinal taps currently used to diagnose Alzheimer's disease.
The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...
Finger-prick blood tests at home detected Alzheimer's biomarkers nearly as well as standard methods. The DROP-AD study suggested that dried blood spots could revolutionize screening approaches for ...
MedPage Today on MSN
Alzheimer's blood tests together improve accuracy, cut overdiagnosis
Plasma eMTBR-tau243 also could help identify people with high tau burden ...
Add Yahoo as a preferred source to see more of our stories on Google. The US Food and Drug Administration’s (FDA) recent clearance of Roche’s blood-based Alzheimer’s disease test will boost ...
Roche's Elecsys pTau181 test is the second blood-based biomarker test to receive FDA clearance for Alzheimer’s disease this year. - Sarah Silbiger/Getty Images The US Food and Drug Administration has ...
Add Yahoo as a preferred source to see more of our stories on Google. Roche's Elecsys pTau181 test is the second blood-based biomarker test to receive FDA clearance for Alzheimer’s disease this year. ...
The U.S. Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results